Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Garry

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Therapeutic Innovation & Regulatory Science|March 19, 2025
Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private-Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE GenerationNicolle M Gatto, Elizabeth M Garry, Melanie Wang, et al.
Fertility and Sterility|October 15, 2018
Opioid dispensing patterns after oocyte retrievalPietro Bortoletto, Malavika Prabhu, Elizabeth M Garry, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2022
Alternative analytic and matching approaches for the prevalent new-user design: A simulation studyMichael Webster-Clark, Panagiotis Mavros, Elizabeth M Garry, et al.
Respiratory Research|June 18, 2021
Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysisShigeo Muro, Masaru Suzuki, Shuhei Nakamura, et al.
Obstetrics and Gynecology|July 12, 2018
Frequency of Opioid Dispensing After Vaginal DeliveryMalavika Prabhu, Elizabeth M Garry, Sonia Hernandez-Diaz, et al.
Diabetes, Obesity & Metabolism|May 16, 2019
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetesElizabeth M Garry, John B Buse, Mugdha Gokhale, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2024
Clarifying the causal contrast: An empirical example applying the prevalent new user study designJessica C Young, Michael Webster-Clark, Shahar Shmuel, et al.
Advances in Therapy|February 24, 2022
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database AnalysisAmy L Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2023
Characteristics and outcomes of pregnancies in the Maternal Outcomes Masterset real-world databaseLiza R Gibbs, Ayad K Ali, Dawn G Albright, et al.
Rheumatology (Oxford, England)|November 6, 2020
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort studyQiang Li, Laura Wallace, Padmaja Patnaik, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|March 19, 2025
Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private-Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE GenerationNicolle M Gatto, Elizabeth M Garry, Melanie Wang, et al.
Fertility and Sterility|October 15, 2018
Opioid dispensing patterns after oocyte retrievalPietro Bortoletto, Malavika Prabhu, Elizabeth M Garry, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2022
Alternative analytic and matching approaches for the prevalent new-user design: A simulation studyMichael Webster-Clark, Panagiotis Mavros, Elizabeth M Garry, et al.
Respiratory Research|June 18, 2021
Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysisShigeo Muro, Masaru Suzuki, Shuhei Nakamura, et al.
Obstetrics and Gynecology|July 12, 2018
Frequency of Opioid Dispensing After Vaginal DeliveryMalavika Prabhu, Elizabeth M Garry, Sonia Hernandez-Diaz, et al.
Diabetes, Obesity & Metabolism|May 16, 2019
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetesElizabeth M Garry, John B Buse, Mugdha Gokhale, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2024
Clarifying the causal contrast: An empirical example applying the prevalent new user study designJessica C Young, Michael Webster-Clark, Shahar Shmuel, et al.
Advances in Therapy|February 24, 2022
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database AnalysisAmy L Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2023
Characteristics and outcomes of pregnancies in the Maternal Outcomes Masterset real-world databaseLiza R Gibbs, Ayad K Ali, Dawn G Albright, et al.
Rheumatology (Oxford, England)|November 6, 2020
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort studyQiang Li, Laura Wallace, Padmaja Patnaik, et al.
Pageof 4